Cognito Therapeutics
MA - CambridgeBiotechnology
Focus: Cognito Therapeutics is a public-stage biotech company headquartered in Cambridge, MA, focused on device-based brain therapies for neurological disorders, specifically Alzheimer's disease. The company is transitioning from development to commercialization with recent funding and executive appointments signaling market-entry preparation.
Profile data last refreshed 8h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
2-2 this month
Stable — net -2 jobs in 30d
2 added, 4 removed. Backfill posture.
Should You Work at Cognito Therapeutics?
AI assessmentCognito is a high-risk, high-upside early-stage opportunity for candidates seeking neurotech exposure and early equity participation, but with minimal near-term hiring and unproven clinical/commercial validation.
Why Work Here
- Emerging neurotech platform with $105M raised in March 2026 and recent commercial leadership appointments (EVP Alzheimer's Portfolio), indicating growth trajectory and resource availability.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
GammaSense Stimulation System
Alzheimer DiseaseClinical Trials (1)
NCT03556280Multi-Center Study of Sensory Stimulation to Improve Brain Function
N/AHelp build intelligence for Cognito Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.